Current Collaborations

Lipid mediators

---

LONDON

DeltaDot and Dr Cali Hyde in the Bioanalysis lab, at LBIC
Developing new assays for eicosanoid measurements

---

---

Dr Ludo Pelligand





Developing new assays for eicosanoid measurements

---

---

Prof Jane Mitchell, Imperial College London

​Eicosanoids in vascular, respiratory and inflammatory health

---

Dr Sue Barker, School of Pharmacy, UCL.

Therapeutic delivery of lipids
​

London

Prof Derek Gilroy, UCL

Inflammatory resolution 

---

---

Prof Tim Warner, QMUL





Eicosanoid regulation and thrombosis, and beloved local figure

---

---

Prof Magdi Yaqoob, Barts and the London




​Epoxygenase function in Chronic Kidney Disease

---

---

Dr Irilenia Nobeli, Birkbeck




​Molecular modelling of lipid metabolising CYP enzymes

---

---

Dr Jacques Behmoaras, Imperial College London

Epoxygenase function in obesity

International

Prof Darryl Zeldin, NIEHS/ NIH, NC, USA





Epoxygenases in health and disease

---

---

Prof Bruce Hammock, UC Davies, USA




Soluble epoxide hydrolase inhibitors as therapeutic tools for vascular, renal and inflammatory disorders

---

---

Dr Aili Lazaar, GSK, King of Prussia, USA.

​Soluble epoxide hydrolase inhibitors as therapeutic tools for inflammatory disorders.

---

​
Prof Nicole Wagner. University of Nice

PPARb/d in angiogenesis

---

Prof Byeong Jang, Keimyung University, Republic of Korea.

 Marine products for cancer and metabolic diseases

---

Prof Michael Murray, University of Sydney, Australia.

​Epoxy-fatty acid analogues in health and disease

---